Mohammad Vaezi

827 total citations
93 papers, 511 citations indexed

About

Mohammad Vaezi is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Mohammad Vaezi has authored 93 papers receiving a total of 511 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Hematology, 27 papers in Oncology and 16 papers in Molecular Biology. Recurrent topics in Mohammad Vaezi's work include Hematopoietic Stem Cell Transplantation (23 papers), Acute Myeloid Leukemia Research (17 papers) and Acute Lymphoblastic Leukemia research (13 papers). Mohammad Vaezi is often cited by papers focused on Hematopoietic Stem Cell Transplantation (23 papers), Acute Myeloid Leukemia Research (17 papers) and Acute Lymphoblastic Leukemia research (13 papers). Mohammad Vaezi collaborates with scholars based in Iran, United States and United Kingdom. Mohammad Vaezi's co-authors include Ardeshir Ghavamzadeh, Kamran Alimoghaddam, Kheirollah Gholami, Saeed Mohammadi, Molouk Hadjibabaie, Marjan Yaghmaie, Amir Kasaeian, Seyed H. Ghaffari, Seied Asadollah Mousavi and Mahdi Jalili and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Mohammad Vaezi

79 papers receiving 505 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mohammad Vaezi Iran	13	182	133	122	81	59	93	511
Akriti Jain United States	10	134 0.7×	137 1.0×	120 1.0×	47 0.6×	55 0.9×	88	409
Hyery Kim South Korea	16	198 1.1×	152 1.1×	110 0.9×	83 1.0×	74 1.3×	100	665
Maarten Egeler Netherlands	11	258 1.4×	145 1.1×	199 1.6×	95 1.2×	54 0.9×	29	769
Theodore Thomas United States	11	181 1.0×	137 1.0×	160 1.3×	86 1.1×	68 1.2×	51	551
Anna Pawłowska United States	11	125 0.7×	95 0.7×	124 1.0×	129 1.6×	63 1.1×	44	465
Berthold Hoppe Germany	17	242 1.3×	61 0.5×	110 0.9×	130 1.6×	100 1.7×	50	705
Sam Milliken Australia	12	90 0.5×	158 1.2×	57 0.5×	116 1.4×	48 0.8×	31	576
Omar Fahmy Malaysia	19	137 0.8×	130 1.0×	94 0.8×	57 0.7×	209 3.5×	64	882
Anne‐Marie Langevin United States	12	95 0.5×	113 0.8×	103 0.8×	78 1.0×	133 2.3×	29	518
Peter Waldron United States	13	169 0.9×	117 0.9×	155 1.3×	109 1.3×	60 1.0×	30	641

Countries citing papers authored by Mohammad Vaezi

Since Specialization

Citations

This map shows the geographic impact of Mohammad Vaezi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad Vaezi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad Vaezi more than expected).

Fields of papers citing papers by Mohammad Vaezi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohammad Vaezi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad Vaezi. The network helps show where Mohammad Vaezi may publish in the future.

Co-authorship network of co-authors of Mohammad Vaezi

This figure shows the co-authorship network connecting the top 25 collaborators of Mohammad Vaezi. A scholar is included among the top collaborators of Mohammad Vaezi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohammad Vaezi. Mohammad Vaezi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yaghoubi, Neda, et al.. (2025). Trastuzumab deruxtecan versus trastuzumab emtansine for human epidermal growth factor receptor 2 positive metastatic breast cancer: cost-effectiveness analysis from Iranian experience. BMC Health Services Research. 25(1). 711–711.

Arjmand, Babak, Sepideh Alavi-Moghadam, Mostafa Rezaei–Tavirani, et al.. (2025). The Role of Aging and Senescence in Bone Marrow Transplantation Outcome. Advances in experimental medicine and biology. 1488. 133–160. 1 indexed citations

Mousavi, Seied Asadollah, et al.. (2024). Determining the predictive impact of donor parity on the outcomes of human leukocyte antigen matched hematopoietic stem cell transplants: a retrospective, single-center study. Frontiers in Oncology. 14. 1339605–1339605. 1 indexed citations

Mousavi, Seyed Reza, et al.. (2024). Predictive modeling of outcomes in acute leukemia patients undergoing allogeneic hematopoietic stem cell transplantation using machine learning techniques. Leukemia Research. 148. 107619–107619. 1 indexed citations

Ahmadvand, Mohammad, Hossein Pashaiefar, Amir Kasaeian, et al.. (2024). Diagnosis of Cutaneous Acute Graft‑Versus‑Host Disease Through Circulating Plasma miR‐638, miR‐6511b‐5p, miR‐3613‐5p, miR‐455‐3p, miR‐5787, and miR‐548a‐3p as Prospective Noninvasive Biomarkers Following Allogeneic Hematopoietic Stem Cell Transplantation. Clinical Transplantation. 38(6). e15371–e15371.

Vaezi, Mohammad, et al.. (2024). Immediate hypersensitivity reactions to parenteral cyclosporine in patients with thalassemia major undergoing hematopoietic stem cell transplantation: a case report and review of the literature. Journal of Medical Case Reports. 18(1). 544–544.

Vaezi, Mohammad, et al.. (2024). Assessment of drug-drug interactions among patients with hematologic malignancy: A clinical pharmacist-led study. Journal of Oncology Pharmacy Practice. 31(8). 1256–1263.

Abdollahı, Mohammad, et al.. (2024). Oral regimen for high dose methotrexate urine alkalinization: a systematic review and meta-analysis. DARU Journal of Pharmaceutical Sciences. 32(1). 353–377. 1 indexed citations

Yaghmaie, Marjan, et al.. (2024). Efficacy and safety of adoptive T‐cell therapy in treating cytomegalovirus infections post‐haematopoietic stem cell transplantation: A systematic review and meta‐analysis. Reviews in Medical Virology. 34(4). e2558–e2558. 4 indexed citations

10.

Tavakoli, Shirin, et al.. (2024). CAR-NK Cells as Promising Immune Therapeutics: Platforms and Current Progress. International Journal of Cancer Management. 17(1). 2 indexed citations

11.

Amiri, Fahimeh Bagheri, et al.. (2023). Evaluation of Safety and Immunogenicity of a Recombinant Receptor-Binding Domain (RBD)-Tetanus Toxoid (TT) Conjugated SARS-CoV-2 Vaccine (PastoCovac) in Recipients of Autologous Hematopoietic Stem Cell Transplantation Compared to the Healthy Controls; A Prospective, Open-Label Clinical Trial. Vaccines. 11(1). 117–117. 2 indexed citations

12.

Karami, Manoochehr, et al.. (2023). Homologous versus Heterologous prime-boost COVID-19 Vaccination in autologous hematopoietic stem cell transplantation recipients: a blinded randomized controlled trial. Frontiers in Immunology. 14. 1237916–1237916. 4 indexed citations

13.

Vaezi, Mohammad, et al.. (2023). Pharmacotherapy Considerations in Antiemetic Prophylaxis for Chemotherapy-Induced Nausea and Vomiting. European Journal of Cancer Care. 2023. 1–11. 1 indexed citations

14.

Tavakoli, Sahar, Amir Kasaeian, Seyed Ali Mousavi, et al.. (2023). Comparable Outcomes of Pre- Versus Post-Tyrosine Kinase Inhibitor Era Treatment in Chronic Myeloid Leukemia: A Retrospective Cohort Study With Long-term Follow-up. Cell Transplantation. 32. 4231221068–4231221068. 2 indexed citations

15.

Kargar, Mona, et al.. (2022). Adherence to practice guidelines for the management of febrile neutropenia in patients undergoing hematopoietic stem cell transplantation: An observational study in a referral center in Iran. Journal of Oncology Pharmacy Practice. 29(5). 1112–1118. 1 indexed citations

16.

Haghazali, Mehrdad, Azin Alizadehasl, Akbar Biglarian, et al.. (2021). Echocardiographic Follow-Up in HER2 Positive and Negative Breast Cancer Patients: Is There a Sustained Decline in Left Ventricular Function Parameters Following Chemotherapy?.

17.

Anvari, Saeid, et al.. (2019). Efficacy and Safety of the Irinotecan, Capecitabine, and Oxaliplatin (IOX) Regimen in Metastatic Gastric Cancer: A Single Arm Phase II Trial. SHILAP Revista de lepidopterología.

18.

Shamshiri, Ahmad Reza, Bahram Chahardouli, Molouk Hadjibabaie, et al.. (2019). Oral calcitriol in hematopoietic recovery and survival after autologous stem cell transplantation: a randomized clinical trial. DARU Journal of Pharmaceutical Sciences. 27(2). 709–720. 11 indexed citations

19.

Vaezi, Mohammad, et al.. (2016). Platelet Transfusion Outcome and Flow Cytometric Monocyte Phagocytic Assay (FMPA).. PubMed. 19(6). 426–9.

20.

Alimoghaddam, Kamran, Babak Bahar, Amir Ali Hamidieh, et al.. (2012). Allogeneic stem Cell Transplantation outcome in acute Lymphoblastic Leukemia Patients. SHILAP Revista de lepidopterología. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact